Anti-Parkinson Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: A9938707883BEN
Market Monitor Global

Abstracts

Anti-Parkinson Drugs are drugs used to treat Parkinson's disease.

This report contains market size and forecasts of Anti-Parkinson Drugs in Global, including the following market information:

Global Anti-Parkinson Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti-Parkinson Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Dopaminergic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-Parkinson Drugs include AbbVie, Mylan Laboratories, Valeant Pharmaceuticals, Novartis, GlaxoSmithKline, Zambon Pharmaceuticals, Pfizer, Inc., Hoffmann-La Roche and Merck & Co., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Parkinson Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-Parkinson Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti-Parkinson Drugs Market Segment Percentages, by Type, 2021 (%)

• Dopaminergic
• Dopamine Agonists
• Enzyme Inhibitors
• Others

Global Anti-Parkinson Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti-Parkinson Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Stores

Global Anti-Parkinson Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti-Parkinson Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-Parkinson Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti-Parkinson Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Mylan Laboratories
• Valeant Pharmaceuticals
• Novartis
• GlaxoSmithKline
• Zambon Pharmaceuticals
• Pfizer, Inc.
• Hoffmann-La Roche
• Merck & Co.
• Orion Pharma
• UCB
• Teva Pharmaceutical Industries Ltd.
• Vertical Pharmaceuticals, LLC
• ACADIA Pharmaceuticals Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-Parkinson Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-Parkinson Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-PARKINSON DRUGS OVERALL MARKET SIZE

2.1 Global Anti-Parkinson Drugs Market Size: 2021 VS 2028
2.2 Global Anti-Parkinson Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-Parkinson Drugs Players in Global Market
3.2 Top Global Anti-Parkinson Drugs Companies Ranked by Revenue
3.3 Global Anti-Parkinson Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-Parkinson Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-Parkinson Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Parkinson Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Anti-Parkinson Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-Parkinson Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti-Parkinson Drugs Market Size Markets, 2021 & 2028
  4.1.2 Dopaminergic
  4.1.3 Dopamine Agonists
  4.1.4 Enzyme Inhibitors
  4.1.5 Others
4.2 By Type - Global Anti-Parkinson Drugs Revenue & Forecasts
  4.2.1 By Type - Global Anti-Parkinson Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Anti-Parkinson Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Anti-Parkinson Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-Parkinson Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Stores
5.2 By Application - Global Anti-Parkinson Drugs Revenue & Forecasts
  5.2.1 By Application - Global Anti-Parkinson Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Anti-Parkinson Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Anti-Parkinson Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-Parkinson Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anti-Parkinson Drugs Revenue & Forecasts
  6.2.1 By Region - Global Anti-Parkinson Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Anti-Parkinson Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Anti-Parkinson Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti-Parkinson Drugs Revenue, 2017-2028
  6.3.2 US Anti-Parkinson Drugs Market Size, 2017-2028
  6.3.3 Canada Anti-Parkinson Drugs Market Size, 2017-2028
  6.3.4 Mexico Anti-Parkinson Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti-Parkinson Drugs Revenue, 2017-2028
  6.4.2 Germany Anti-Parkinson Drugs Market Size, 2017-2028
  6.4.3 France Anti-Parkinson Drugs Market Size, 2017-2028
  6.4.4 U.K. Anti-Parkinson Drugs Market Size, 2017-2028
  6.4.5 Italy Anti-Parkinson Drugs Market Size, 2017-2028
  6.4.6 Russia Anti-Parkinson Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Anti-Parkinson Drugs Market Size, 2017-2028
  6.4.8 Benelux Anti-Parkinson Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti-Parkinson Drugs Revenue, 2017-2028
  6.5.2 China Anti-Parkinson Drugs Market Size, 2017-2028
  6.5.3 Japan Anti-Parkinson Drugs Market Size, 2017-2028
  6.5.4 South Korea Anti-Parkinson Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Anti-Parkinson Drugs Market Size, 2017-2028
  6.5.6 India Anti-Parkinson Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti-Parkinson Drugs Revenue, 2017-2028
  6.6.2 Brazil Anti-Parkinson Drugs Market Size, 2017-2028
  6.6.3 Argentina Anti-Parkinson Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-Parkinson Drugs Revenue, 2017-2028
  6.7.2 Turkey Anti-Parkinson Drugs Market Size, 2017-2028
  6.7.3 Israel Anti-Parkinson Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti-Parkinson Drugs Market Size, 2017-2028
  6.7.5 UAE Anti-Parkinson Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Anti-Parkinson Drugs Major Product Offerings
  7.1.4 AbbVie Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Mylan Laboratories
  7.2.1 Mylan Laboratories Corporate Summary
  7.2.2 Mylan Laboratories Business Overview
  7.2.3 Mylan Laboratories Anti-Parkinson Drugs Major Product Offerings
  7.2.4 Mylan Laboratories Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.2.5 Mylan Laboratories Key News
7.3 Valeant Pharmaceuticals
  7.3.1 Valeant Pharmaceuticals Corporate Summary
  7.3.2 Valeant Pharmaceuticals Business Overview
  7.3.3 Valeant Pharmaceuticals Anti-Parkinson Drugs Major Product Offerings
  7.3.4 Valeant Pharmaceuticals Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.3.5 Valeant Pharmaceuticals Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Anti-Parkinson Drugs Major Product Offerings
  7.4.4 Novartis Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Anti-Parkinson Drugs Major Product Offerings
  7.5.4 GlaxoSmithKline Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 Zambon Pharmaceuticals
  7.6.1 Zambon Pharmaceuticals Corporate Summary
  7.6.2 Zambon Pharmaceuticals Business Overview
  7.6.3 Zambon Pharmaceuticals Anti-Parkinson Drugs Major Product Offerings
  7.6.4 Zambon Pharmaceuticals Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.6.5 Zambon Pharmaceuticals Key News
7.7 Pfizer, Inc.
  7.7.1 Pfizer, Inc. Corporate Summary
  7.7.2 Pfizer, Inc. Business Overview
  7.7.3 Pfizer, Inc. Anti-Parkinson Drugs Major Product Offerings
  7.7.4 Pfizer, Inc. Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.7.5 Pfizer, Inc. Key News
7.8 Hoffmann-La Roche
  7.8.1 Hoffmann-La Roche Corporate Summary
  7.8.2 Hoffmann-La Roche Business Overview
  7.8.3 Hoffmann-La Roche Anti-Parkinson Drugs Major Product Offerings
  7.8.4 Hoffmann-La Roche Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.8.5 Hoffmann-La Roche Key News
7.9 Merck & Co.
  7.9.1 Merck & Co. Corporate Summary
  7.9.2 Merck & Co. Business Overview
  7.9.3 Merck & Co. Anti-Parkinson Drugs Major Product Offerings
  7.9.4 Merck & Co. Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.9.5 Merck & Co. Key News
7.10 Orion Pharma
  7.10.1 Orion Pharma Corporate Summary
  7.10.2 Orion Pharma Business Overview
  7.10.3 Orion Pharma Anti-Parkinson Drugs Major Product Offerings
  7.10.4 Orion Pharma Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.10.5 Orion Pharma Key News
7.11 UCB
  7.11.1 UCB Corporate Summary
  7.11.2 UCB Business Overview
  7.11.3 UCB Anti-Parkinson Drugs Major Product Offerings
  7.11.4 UCB Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.11.5 UCB Key News
7.12 Teva Pharmaceutical Industries Ltd.
  7.12.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
  7.12.2 Teva Pharmaceutical Industries Ltd. Business Overview
  7.12.3 Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Major Product Offerings
  7.12.4 Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.12.5 Teva Pharmaceutical Industries Ltd. Key News
7.13 Vertical Pharmaceuticals, LLC
  7.13.1 Vertical Pharmaceuticals, LLC Corporate Summary
  7.13.2 Vertical Pharmaceuticals, LLC Business Overview
  7.13.3 Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Major Product Offerings
  7.13.4 Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.13.5 Vertical Pharmaceuticals, LLC Key News
7.14 ACADIA Pharmaceuticals Inc.
  7.14.1 ACADIA Pharmaceuticals Inc. Corporate Summary
  7.14.2 ACADIA Pharmaceuticals Inc. Business Overview
  7.14.3 ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Major Product Offerings
  7.14.4 ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Revenue in Global Market (2017-2022)
  7.14.5 ACADIA Pharmaceuticals Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti-Parkinson Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-Parkinson Drugs Market Drivers in Global Market
Table 3. Anti-Parkinson Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-Parkinson Drugs in Global Market
Table 5. Top Anti-Parkinson Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-Parkinson Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-Parkinson Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-Parkinson Drugs Product Type
Table 9. List of Global Tier 1 Anti-Parkinson Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Parkinson Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-Parkinson Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-Parkinson Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-Parkinson Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-Parkinson Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-Parkinson Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-Parkinson Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-Parkinson Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Anti-Parkinson Drugs Product Offerings
Table 32. AbbVie Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Mylan Laboratories Corporate Summary
Table 34. Mylan Laboratories Anti-Parkinson Drugs Product Offerings
Table 35. Mylan Laboratories Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Valeant Pharmaceuticals Corporate Summary
Table 37. Valeant Pharmaceuticals Anti-Parkinson Drugs Product Offerings
Table 38. Valeant Pharmaceuticals Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Anti-Parkinson Drugs Product Offerings
Table 41. Novartis Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Anti-Parkinson Drugs Product Offerings
Table 44. GlaxoSmithKline Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Zambon Pharmaceuticals Corporate Summary
Table 46. Zambon Pharmaceuticals Anti-Parkinson Drugs Product Offerings
Table 47. Zambon Pharmaceuticals Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer, Inc. Corporate Summary
Table 49. Pfizer, Inc. Anti-Parkinson Drugs Product Offerings
Table 50. Pfizer, Inc. Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Hoffmann-La Roche Corporate Summary
Table 52. Hoffmann-La Roche Anti-Parkinson Drugs Product Offerings
Table 53. Hoffmann-La Roche Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Merck & Co. Corporate Summary
Table 55. Merck & Co. Anti-Parkinson Drugs Product Offerings
Table 56. Merck & Co. Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Orion Pharma Corporate Summary
Table 58. Orion Pharma Anti-Parkinson Drugs Product Offerings
Table 59. Orion Pharma Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 60. UCB Corporate Summary
Table 61. UCB Anti-Parkinson Drugs Product Offerings
Table 62. UCB Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 64. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product Offerings
Table 65. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Vertical Pharmaceuticals, LLC Corporate Summary
Table 67. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product Offerings
Table 68. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
Table 69. ACADIA Pharmaceuticals Inc. Corporate Summary
Table 70. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product Offerings
Table 71. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-Parkinson Drugs Segment by Type in 2021
Figure 2. Anti-Parkinson Drugs Segment by Application in 2021
Figure 3. Global Anti-Parkinson Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-Parkinson Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-Parkinson Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Parkinson Drugs Revenue in 2021
Figure 8. By Type - Global Anti-Parkinson Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-Parkinson Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-Parkinson Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-Parkinson Drugs Revenue Market Share, 2017-2028
Figure 12. US Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-Parkinson Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-Parkinson Drugs Revenue Market Share, 2017-2028
Figure 24. China Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-Parkinson Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-Parkinson Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mylan Laboratories Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Valeant Pharmaceuticals Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Zambon Pharmaceuticals Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer, Inc. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hoffmann-La Roche Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck & Co. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Orion Pharma Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. UCB Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)